Effect of aerobic training and pomegranate juice consumption on liver Fat, liver enzymes and lipid profile

The Interaction and separate works of 8 weeks aerobic exercise and pomegranate juice consumption on levels of liver enzymes, insulin resistance and lipid profiles in men with type II diabetes

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200907048650N1

Enrollment

Registered

2020-10-24

Start date

2020-11-10

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: The aerobic training + pomegranate juice supplementation Intervention will be consists of 40-60 minutes of aerobic exercise at 60% - 75% of HRmax, 3 times a week fo

Eligibility

Sex/Gender

Male

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Not having a specific diet and regular exercise program in the past year Confirmation of a diagnosis of diabetes by an internal medicine doctor (people with high blood sugar above 126 mg) Body mass index from 24.99 upwards

Exclusion criteria

Exclusion criteria: Presence of other liver diseases (B and C hepatitis) Surgical treatment of obesity or severe weight loss Presence of any other chronic disease or skeletal disorders Presence of Other disorders such as autoimmune hepatitis, Presence of joint disease Presence of coronary artery disease Presence of kidney failure disease Presence of hypothyroidism

Design outcomes

Primary

Measure	Time frame
Lipid profile. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Serum levels of liver enzymes. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Glucose and insulin levels. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Blood pressure. Timepoint: Before the study starts and after it ended. Method of measurement: Digital sphygmomanometer.	—

Measure

Time frame

Lipid profile. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Serum levels of liver enzymes. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Glucose and insulin levels. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Blood pressure. Timepoint: Before the study starts and after it ended. Method of measurement: Digital sphygmomanometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRastegar Hoseini

Razi University

R.hoseini@razi.ac.ir+98 83 3428 3267

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026